Key result
Myocardial perfusion scintigraphy predicts event-free survival better than coronary angiography in women with suspected CAD.
Why the study?
Does myocardial perfusion scintigraphy provide better prognostic value for cardiovascular events compared to coronary angiography in women with suspected CAD and positive stress test results?
Observational (n=115)
Does myocardial perfusion scintigraphy provide better prognostic value for cardiovascular events compared to coronary angiography in women with suspected CAD and positive stress test results?
p-value: p=< 0.01
Myocardial perfusion scintigraphy offers superior prognostic value compared to coronary angiography for predicting cardiovascular events in women with suspected CAD and positive stress tests.
MPS may better predict events than angiography in women with positive stress tests; leaves open whether findings should alter diagnostic pathways.
No takes yet. Share an insight, caveat, or question.
Miernik et al. (2012) conducted an observational in Suspected coronary artery disease (n=115). Myocardial perfusion scintigraphy vs. Coronary angiography was evaluated on Cardiovascular events (p=< 0.01). Myocardial perfusion scintigraphy was a better predictor of survival without cardiovascular events than coronary angiography (sensitivity 100% vs 92.3%; p < 0.01) in women with suspected CAD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: